Click for best price
Osteosarcoma Drug Market Size, Share 2024
The global Osteosarcoma Drug market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Methotrexate Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Osteosarcoma Drug include Pfizer Inc, Mylan NV, Novartis AG, Hikma Pharmaceuticals plc, Aurobindo Pharma, Melinta Therapeutics, Inc, Bristol-Myers Squibb Company, GSK plc and Bayer AG, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Radiation therapy may be used for tumors that remain unresectable after preoperative chemotherapy. The recommended drugs for preoperative chemotherapy for osteosarcoma are high-dose methotrexate, ifosfamide, doxorubicin, etc., and sequential or combined drug administration can be considered. Each patient should choose two or more drugs via arterial or intravenous administration. Administration (MTX, IFO are not suitable for arterial administration).
This report aims to provide a comprehensive presentation of the global market for Osteosarcoma Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Osteosarcoma Drug. This report contains market size and forecasts of Osteosarcoma Drug in global, including the following market information:
Global Osteosarcoma Drug Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Osteosarcoma Drug Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Osteosarcoma Drug companies in 2023 (%)
We surveyed the Osteosarcoma Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Osteosarcoma Drug Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Osteosarcoma Drug Market Segment Percentages, by Type, 2023 (%)
Methotrexate
Cyclophosphamide
Adriamycin
Other
Global Osteosarcoma Drug Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Osteosarcoma Drug Market Segment Percentages, by Application, 2023 (%)
Hospital
Specialist Clinic
Other
Global Osteosarcoma Drug Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Osteosarcoma Drug Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Osteosarcoma Drug revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Osteosarcoma Drug revenues share in global market, 2023 (%)
Key companies Osteosarcoma Drug sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Osteosarcoma Drug sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer Inc
Mylan NV
Novartis AG
Hikma Pharmaceuticals plc
Aurobindo Pharma
Melinta Therapeutics, Inc
Bristol-Myers Squibb Company
GSK plc
Bayer AG
Teva Pharmaceuticals Industries Ltd
Lilly
AstraZeneca
Amgen Inc
Bellicum Phamaceuticals, Inc
Incyte
Outline of Major Chapters:
Chapter 1: Introduces the definition of Osteosarcoma Drug, market overview.
Chapter 2: Global Osteosarcoma Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Osteosarcoma Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Osteosarcoma Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Osteosarcoma Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Osteosarcoma Drug Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
117 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Osteosarcoma Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Osteosarcoma Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Osteosarcoma Drug Overall Market Size
2.1 Global Osteosarcoma Drug Market Size: 2023 VS 2030
2.2 Global Osteosarcoma Drug Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Osteosarcoma Drug Sales: 2019-2030
3 Company Landscape
3.1 Top Osteosarcoma Drug Players in Global Market
3.2 Top Global Osteosarcoma Drug Companies Ranked by Revenue
3.3 Global Osteosarcoma Drug Revenue by Companies
3.4 Global Osteosarcoma Drug Sales by Companies
3.5 Global Osteosarcoma Drug Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Osteosarcoma Drug Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Osteosarcoma Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Osteosarcoma Drug Players in Global Market
3.8.1 List of Global Tier 1 Osteosarcoma Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Osteosarcoma Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Osteosarcoma Drug Market Size Markets, 2023 & 2030
4.1.2 Methotrexate
4.1.3 Cyclophosphamide
4.1.4 Adriamycin
4.1.5 Other
4.2 By Type - Global Osteosarcoma Drug Revenue & Forecasts
4.2.1 By Type - Global Osteosarcoma Drug Revenue, 2019-2024
4.2.2 By Type - Global Osteosarcoma Drug Revenue, 2025-2030
4.2.3 By Type - Global Osteosarcoma Drug Revenue Market Share, 2019-2030
4.3 By Type - Global Osteosarcoma Drug Sales & Forecasts
4.3.1 By Type - Global Osteosarcoma Drug Sales, 2019-2024
4.3.2 By Type - Global Osteosarcoma Drug Sales, 2025-2030
4.3.3 By Type - Global Osteosarcoma Drug Sales Market Share, 2019-2030
4.4 By Type - Global Osteosarcoma Drug Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Osteosarcoma Drug Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Specialist Clinic
5.1.4 Other
5.2 By Application - Global Osteosarcoma Drug Revenue & Forecasts
5.2.1 By Application - Global Osteosarcoma Drug Revenue, 2019-2024
5.2.2 By Application - Global Osteosarcoma Drug Revenue, 2025-2030
5.2.3 By Application - Global Osteosarcoma Drug Revenue Market Share, 2019-2030
5.3 By Application - Global Osteosarcoma Drug Sales & Forecasts
5.3.1 By Application - Global Osteosarcoma Drug Sales, 2019-2024
5.3.2 By Application - Global Osteosarcoma Drug Sales, 2025-2030
5.3.3 By Application - Global Osteosarcoma Drug Sales Market Share, 2019-2030
5.4 By Application - Global Osteosarcoma Drug Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Osteosarcoma Drug Market Size, 2023 & 2030
6.2 By Region - Global Osteosarcoma Drug Revenue & Forecasts
6.2.1 By Region - Global Osteosarcoma Drug Revenue, 2019-2024
6.2.2 By Region - Global Osteosarcoma Drug Revenue, 2025-2030
6.2.3 By Region - Global Osteosarcoma Drug Revenue Market Share, 2019-2030
6.3 By Region - Global Osteosarcoma Drug Sales & Forecasts
6.3.1 By Region - Global Osteosarcoma Drug Sales, 2019-2024
6.3.2 By Region - Global Osteosarcoma Drug Sales, 2025-2030
6.3.3 By Region - Global Osteosarcoma Drug Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Osteosarcoma Drug Revenue, 2019-2030
6.4.2 By Country - North America Osteosarcoma Drug Sales, 2019-2030
6.4.3 US Osteosarcoma Drug Market Size, 2019-2030
6.4.4 Canada Osteosarcoma Drug Market Size, 2019-2030
6.4.5 Mexico Osteosarcoma Drug Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Osteosarcoma Drug Revenue, 2019-2030
6.5.2 By Country - Europe Osteosarcoma Drug Sales, 2019-2030
6.5.3 Germany Osteosarcoma Drug Market Size, 2019-2030
6.5.4 France Osteosarcoma Drug Market Size, 2019-2030
6.5.5 U.K. Osteosarcoma Drug Market Size, 2019-2030
6.5.6 Italy Osteosarcoma Drug Market Size, 2019-2030
6.5.7 Russia Osteosarcoma Drug Market Size, 2019-2030
6.5.8 Nordic Countries Osteosarcoma Drug Market Size, 2019-2030
6.5.9 Benelux Osteosarcoma Drug Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Osteosarcoma Drug Revenue, 2019-2030
6.6.2 By Region - Asia Osteosarcoma Drug Sales, 2019-2030
6.6.3 China Osteosarcoma Drug Market Size, 2019-2030
6.6.4 Japan Osteosarcoma Drug Market Size, 2019-2030
6.6.5 South Korea Osteosarcoma Drug Market Size, 2019-2030
6.6.6 Southeast Asia Osteosarcoma Drug Market Size, 2019-2030
6.6.7 India Osteosarcoma Drug Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Osteosarcoma Drug Revenue, 2019-2030
6.7.2 By Country - South America Osteosarcoma Drug Sales, 2019-2030
6.7.3 Brazil Osteosarcoma Drug Market Size, 2019-2030
6.7.4 Argentina Osteosarcoma Drug Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Osteosarcoma Drug Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Osteosarcoma Drug Sales, 2019-2030
6.8.3 Turkey Osteosarcoma Drug Market Size, 2019-2030
6.8.4 Israel Osteosarcoma Drug Market Size, 2019-2030
6.8.5 Saudi Arabia Osteosarcoma Drug Market Size, 2019-2030
6.8.6 UAE Osteosarcoma Drug Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Pfizer Inc
7.1.1 Pfizer Inc Company Summary
7.1.2 Pfizer Inc Business Overview
7.1.3 Pfizer Inc Osteosarcoma Drug Major Product Offerings
7.1.4 Pfizer Inc Osteosarcoma Drug Sales and Revenue in Global (2019-2024)
7.1.5 Pfizer Inc Key News & Latest Developments
7.2 Mylan NV
7.2.1 Mylan NV Company Summary
7.2.2 Mylan NV Business Overview
7.2.3 Mylan NV Osteosarcoma Drug Major Product Offerings
7.2.4 Mylan NV Osteosarcoma Drug Sales and Revenue in Global (2019-2024)
7.2.5 Mylan NV Key News & Latest Developments
7.3 Novartis AG
7.3.1 Novartis AG Company Summary
7.3.2 Novartis AG Business Overview
7.3.3 Novartis AG Osteosarcoma Drug Major Product Offerings
7.3.4 Novartis AG Osteosarcoma Drug Sales and Revenue in Global (2019-2024)
7.3.5 Novartis AG Key News & Latest Developments
7.4 Hikma Pharmaceuticals plc
7.4.1 Hikma Pharmaceuticals plc Company Summary
7.4.2 Hikma Pharmaceuticals plc Business Overview
7.4.3 Hikma Pharmaceuticals plc Osteosarcoma Drug Major Product Offerings
7.4.4 Hikma Pharmaceuticals plc Osteosarcoma Drug Sales and Revenue in Global (2019-2024)
7.4.5 Hikma Pharmaceuticals plc Key News & Latest Developments
7.5 Aurobindo Pharma
7.5.1 Aurobindo Pharma Company Summary
7.5.2 Aurobindo Pharma Business Overview
7.5.3 Aurobindo Pharma Osteosarcoma Drug Major Product Offerings
7.5.4 Aurobindo Pharma Osteosarcoma Drug Sales and Revenue in Global (2019-2024)
7.5.5 Aurobindo Pharma Key News & Latest Developments
7.6 Melinta Therapeutics, Inc
7.6.1 Melinta Therapeutics, Inc Company Summary
7.6.2 Melinta Therapeutics, Inc Business Overview
7.6.3 Melinta Therapeutics, Inc Osteosarcoma Drug Major Product Offerings
7.6.4 Melinta Therapeutics, Inc Osteosarcoma Drug Sales and Revenue in Global (2019-2024)
7.6.5 Melinta Therapeutics, Inc Key News & Latest Developments
7.7 Bristol-Myers Squibb Company
7.7.1 Bristol-Myers Squibb Company Company Summary
7.7.2 Bristol-Myers Squibb Company Business Overview
7.7.3 Bristol-Myers Squibb Company Osteosarcoma Drug Major Product Offerings
7.7.4 Bristol-Myers Squibb Company Osteosarcoma Drug Sales and Revenue in Global (2019-2024)
7.7.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.8 GSK plc
7.8.1 GSK plc Company Summary
7.8.2 GSK plc Business Overview
7.8.3 GSK plc Osteosarcoma Drug Major Product Offerings
7.8.4 GSK plc Osteosarcoma Drug Sales and Revenue in Global (2019-2024)
7.8.5 GSK plc Key News & Latest Developments
7.9 Bayer AG
7.9.1 Bayer AG Company Summary
7.9.2 Bayer AG Business Overview
7.9.3 Bayer AG Osteosarcoma Drug Major Product Offerings
7.9.4 Bayer AG Osteosarcoma Drug Sales and Revenue in Global (2019-2024)
7.9.5 Bayer AG Key News & Latest Developments
7.10 Teva Pharmaceuticals Industries Ltd
7.10.1 Teva Pharmaceuticals Industries Ltd Company Summary
7.10.2 Teva Pharmaceuticals Industries Ltd Business Overview
7.10.3 Teva Pharmaceuticals Industries Ltd Osteosarcoma Drug Major Product Offerings
7.10.4 Teva Pharmaceuticals Industries Ltd Osteosarcoma Drug Sales and Revenue in Global (2019-2024)
7.10.5 Teva Pharmaceuticals Industries Ltd Key News & Latest Developments
7.11 Lilly
7.11.1 Lilly Company Summary
7.11.2 Lilly Osteosarcoma Drug Business Overview
7.11.3 Lilly Osteosarcoma Drug Major Product Offerings
7.11.4 Lilly Osteosarcoma Drug Sales and Revenue in Global (2019-2024)
7.11.5 Lilly Key News & Latest Developments
7.12 AstraZeneca
7.12.1 AstraZeneca Company Summary
7.12.2 AstraZeneca Osteosarcoma Drug Business Overview
7.12.3 AstraZeneca Osteosarcoma Drug Major Product Offerings
7.12.4 AstraZeneca Osteosarcoma Drug Sales and Revenue in Global (2019-2024)
7.12.5 AstraZeneca Key News & Latest Developments
7.13 Amgen Inc
7.13.1 Amgen Inc Company Summary
7.13.2 Amgen Inc Osteosarcoma Drug Business Overview
7.13.3 Amgen Inc Osteosarcoma Drug Major Product Offerings
7.13.4 Amgen Inc Osteosarcoma Drug Sales and Revenue in Global (2019-2024)
7.13.5 Amgen Inc Key News & Latest Developments
7.14 Bellicum Phamaceuticals, Inc
7.14.1 Bellicum Phamaceuticals, Inc Company Summary
7.14.2 Bellicum Phamaceuticals, Inc Business Overview
7.14.3 Bellicum Phamaceuticals, Inc Osteosarcoma Drug Major Product Offerings
7.14.4 Bellicum Phamaceuticals, Inc Osteosarcoma Drug Sales and Revenue in Global (2019-2024)
7.14.5 Bellicum Phamaceuticals, Inc Key News & Latest Developments
7.15 Incyte
7.15.1 Incyte Company Summary
7.15.2 Incyte Business Overview
7.15.3 Incyte Osteosarcoma Drug Major Product Offerings
7.15.4 Incyte Osteosarcoma Drug Sales and Revenue in Global (2019-2024)
7.15.5 Incyte Key News & Latest Developments
8 Global Osteosarcoma Drug Production Capacity, Analysis
8.1 Global Osteosarcoma Drug Production Capacity, 2019-2030
8.2 Osteosarcoma Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Osteosarcoma Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Osteosarcoma Drug Supply Chain Analysis
10.1 Osteosarcoma Drug Industry Value Chain
10.2 Osteosarcoma Drug Upstream Market
10.3 Osteosarcoma Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Osteosarcoma Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Osteosarcoma Drug in Global Market
Table 2. Top Osteosarcoma Drug Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Osteosarcoma Drug Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Osteosarcoma Drug Revenue Share by Companies, 2019-2024
Table 5. Global Osteosarcoma Drug Sales by Companies, (K Units), 2019-2024
Table 6. Global Osteosarcoma Drug Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Osteosarcoma Drug Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Osteosarcoma Drug Product Type
Table 9. List of Global Tier 1 Osteosarcoma Drug Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Osteosarcoma Drug Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Osteosarcoma Drug Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Osteosarcoma Drug Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Osteosarcoma Drug Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Osteosarcoma Drug Sales (K Units), 2019-2024
Table 15. By Type - Global Osteosarcoma Drug Sales (K Units), 2025-2030
Table 16. By Application ? Global Osteosarcoma Drug Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Osteosarcoma Drug Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Osteosarcoma Drug Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Osteosarcoma Drug Sales (K Units), 2019-2024
Table 20. By Application - Global Osteosarcoma Drug Sales (K Units), 2025-2030
Table 21. By Region ? Global Osteosarcoma Drug Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Osteosarcoma Drug Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Osteosarcoma Drug Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Osteosarcoma Drug Sales (K Units), 2019-2024
Table 25. By Region - Global Osteosarcoma Drug Sales (K Units), 2025-2030
Table 26. By Country - North America Osteosarcoma Drug Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Osteosarcoma Drug Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Osteosarcoma Drug Sales, (K Units), 2019-2024
Table 29. By Country - North America Osteosarcoma Drug Sales, (K Units), 2025-2030
Table 30. By Country - Europe Osteosarcoma Drug Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Osteosarcoma Drug Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Osteosarcoma Drug Sales, (K Units), 2019-2024
Table 33. By Country - Europe Osteosarcoma Drug Sales, (K Units), 2025-2030
Table 34. By Region - Asia Osteosarcoma Drug Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Osteosarcoma Drug Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Osteosarcoma Drug Sales, (K Units), 2019-2024
Table 37. By Region - Asia Osteosarcoma Drug Sales, (K Units), 2025-2030
Table 38. By Country - South America Osteosarcoma Drug Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Osteosarcoma Drug Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Osteosarcoma Drug Sales, (K Units), 2019-2024
Table 41. By Country - South America Osteosarcoma Drug Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Osteosarcoma Drug Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Osteosarcoma Drug Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Osteosarcoma Drug Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Osteosarcoma Drug Sales, (K Units), 2025-2030
Table 46. Pfizer Inc Company Summary
Table 47. Pfizer Inc Osteosarcoma Drug Product Offerings
Table 48. Pfizer Inc Osteosarcoma Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Pfizer Inc Key News & Latest Developments
Table 50. Mylan NV Company Summary
Table 51. Mylan NV Osteosarcoma Drug Product Offerings
Table 52. Mylan NV Osteosarcoma Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Mylan NV Key News & Latest Developments
Table 54. Novartis AG Company Summary
Table 55. Novartis AG Osteosarcoma Drug Product Offerings
Table 56. Novartis AG Osteosarcoma Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Novartis AG Key News & Latest Developments
Table 58. Hikma Pharmaceuticals plc Company Summary
Table 59. Hikma Pharmaceuticals plc Osteosarcoma Drug Product Offerings
Table 60. Hikma Pharmaceuticals plc Osteosarcoma Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Hikma Pharmaceuticals plc Key News & Latest Developments
Table 62. Aurobindo Pharma Company Summary
Table 63. Aurobindo Pharma Osteosarcoma Drug Product Offerings
Table 64. Aurobindo Pharma Osteosarcoma Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Aurobindo Pharma Key News & Latest Developments
Table 66. Melinta Therapeutics, Inc Company Summary
Table 67. Melinta Therapeutics, Inc Osteosarcoma Drug Product Offerings
Table 68. Melinta Therapeutics, Inc Osteosarcoma Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Melinta Therapeutics, Inc Key News & Latest Developments
Table 70. Bristol-Myers Squibb Company Company Summary
Table 71. Bristol-Myers Squibb Company Osteosarcoma Drug Product Offerings
Table 72. Bristol-Myers Squibb Company Osteosarcoma Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Bristol-Myers Squibb Company Key News & Latest Developments
Table 74. GSK plc Company Summary
Table 75. GSK plc Osteosarcoma Drug Product Offerings
Table 76. GSK plc Osteosarcoma Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. GSK plc Key News & Latest Developments
Table 78. Bayer AG Company Summary
Table 79. Bayer AG Osteosarcoma Drug Product Offerings
Table 80. Bayer AG Osteosarcoma Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. Bayer AG Key News & Latest Developments
Table 82. Teva Pharmaceuticals Industries Ltd Company Summary
Table 83. Teva Pharmaceuticals Industries Ltd Osteosarcoma Drug Product Offerings
Table 84. Teva Pharmaceuticals Industries Ltd Osteosarcoma Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. Teva Pharmaceuticals Industries Ltd Key News & Latest Developments
Table 86. Lilly Company Summary
Table 87. Lilly Osteosarcoma Drug Product Offerings
Table 88. Lilly Osteosarcoma Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 89. Lilly Key News & Latest Developments
Table 90. AstraZeneca Company Summary
Table 91. AstraZeneca Osteosarcoma Drug Product Offerings
Table 92. AstraZeneca Osteosarcoma Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 93. AstraZeneca Key News & Latest Developments
Table 94. Amgen Inc Company Summary
Table 95. Amgen Inc Osteosarcoma Drug Product Offerings
Table 96. Amgen Inc Osteosarcoma Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 97. Amgen Inc Key News & Latest Developments
Table 98. Bellicum Phamaceuticals, Inc Company Summary
Table 99. Bellicum Phamaceuticals, Inc Osteosarcoma Drug Product Offerings
Table 100. Bellicum Phamaceuticals, Inc Osteosarcoma Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 101. Bellicum Phamaceuticals, Inc Key News & Latest Developments
Table 102. Incyte Company Summary
Table 103. Incyte Osteosarcoma Drug Product Offerings
Table 104. Incyte Osteosarcoma Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 105. Incyte Key News & Latest Developments
Table 106. Osteosarcoma Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 107. Global Osteosarcoma Drug Capacity Market Share of Key Manufacturers, 2021-2024
Table 108. Global Osteosarcoma Drug Production by Region, 2019-2024 (K Units)
Table 109. Global Osteosarcoma Drug Production by Region, 2025-2030 (K Units)
Table 110. Osteosarcoma Drug Market Opportunities & Trends in Global Market
Table 111. Osteosarcoma Drug Market Drivers in Global Market
Table 112. Osteosarcoma Drug Market Restraints in Global Market
Table 113. Osteosarcoma Drug Raw Materials
Table 114. Osteosarcoma Drug Raw Materials Suppliers in Global Market
Table 115. Typical Osteosarcoma Drug Downstream
Table 116. Osteosarcoma Drug Downstream Clients in Global Market
Table 117. Osteosarcoma Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Osteosarcoma Drug Segment by Type in 2023
Figure 2. Osteosarcoma Drug Segment by Application in 2023
Figure 3. Global Osteosarcoma Drug Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Osteosarcoma Drug Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Osteosarcoma Drug Revenue, 2019-2030 (US$, Mn)
Figure 7. Osteosarcoma Drug Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Osteosarcoma Drug Revenue in 2023
Figure 9. By Type - Global Osteosarcoma Drug Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Osteosarcoma Drug Revenue Market Share, 2019-2030
Figure 11. By Type - Global Osteosarcoma Drug Sales Market Share, 2019-2030
Figure 12. By Type - Global Osteosarcoma Drug Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Osteosarcoma Drug Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Osteosarcoma Drug Revenue Market Share, 2019-2030
Figure 15. By Application - Global Osteosarcoma Drug Sales Market Share, 2019-2030
Figure 16. By Application - Global Osteosarcoma Drug Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Osteosarcoma Drug Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Osteosarcoma Drug Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Osteosarcoma Drug Revenue Market Share, 2019-2030
Figure 20. By Region - Global Osteosarcoma Drug Sales Market Share, 2019-2030
Figure 21. By Country - North America Osteosarcoma Drug Revenue Market Share, 2019-2030
Figure 22. By Country - North America Osteosarcoma Drug Sales Market Share, 2019-2030
Figure 23. US Osteosarcoma Drug Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Osteosarcoma Drug Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Osteosarcoma Drug Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Osteosarcoma Drug Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Osteosarcoma Drug Sales Market Share, 2019-2030
Figure 28. Germany Osteosarcoma Drug Revenue, (US$, Mn), 2019-2030
Figure 29. France Osteosarcoma Drug Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Osteosarcoma Drug Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Osteosarcoma Drug Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Osteosarcoma Drug Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Osteosarcoma Drug Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Osteosarcoma Drug Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Osteosarcoma Drug Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Osteosarcoma Drug Sales Market Share, 2019-2030
Figure 37. China Osteosarcoma Drug Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Osteosarcoma Drug Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Osteosarcoma Drug Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Osteosarcoma Drug Revenue, (US$, Mn), 2019-2030
Figure 41. India Osteosarcoma Drug Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Osteosarcoma Drug Revenue Market Share, 2019-2030
Figure 43. By Country - South America Osteosarcoma Drug Sales Market Share, 2019-2030
Figure 44. Brazil Osteosarcoma Drug Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Osteosarcoma Drug Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Osteosarcoma Drug Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Osteosarcoma Drug Sales Market Share, 2019-2030
Figure 48. Turkey Osteosarcoma Drug Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Osteosarcoma Drug Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Osteosarcoma Drug Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Osteosarcoma Drug Revenue, (US$, Mn), 2019-2030
Figure 52. Global Osteosarcoma Drug Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Osteosarcoma Drug by Region, 2023 VS 2030
Figure 54. Osteosarcoma Drug Industry Value Chain
Figure 55. Marketing Channels
